Guillaume Paré is Director of the Clinical Research Laboratory and Biobank (CRLB) – Genetic and Molecular Epidemiology Laboratory (GMEL), a Professor of Pathology and Molecular Medicine, and a University Scholar at McMaster University.  A practicing clinician-scientist, Dr. Paré completed a Master’s in Human Genetics at McGill University under the supervision of Thomas Hudson. He further trained in genetic epidemiology with Paul Ridker at Harvard Medical School. His clinical interests are centered on lipoprotein disorders, obesity and cardiovascular disease prevention, with research interests in cardiovascular genetics, biomarker development and pharmacogenomics. Dr. Paré’s research combines high-throughput biomarker screens with genetics, bioinformatics and epidemiology to identify novel cardio-metabolic biomarkers. He has published over 340 original contributions in peer-reviewed journals. These include first or last authored articles in the NEJM, Lancet, Circulation, EHJ, Stroke, JACC and Nature family journals. His papers have been cited over 58,000 times with a corresponding-index of 103. Among numerous recognitions, he was inducted to the Royal Society of Canada’s College of New Scholars, Artist and Scientists in 2018.